IS ANTI-FACTOR XA MONITORING BETTER THAN ACTIVATED PARTIALTHROMBOPLASTIN TIME (APTT) IN ACHIEVING THERAPEUTIC RESPONSE TO UNFRACTIONATED HEPARIN?

被引：0
|
作者：
Manzanades, Yuri [1 ]
机构：
[1] West Middlesex Univ Hosp, Isleworth, England
来源：
NURSING IN CRITICAL CARE | 2021年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：30 / 31
页数：2
相关论文
共 50 条
  • [41] Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa Levels
    Dingus, Scott J.
    Smith, Alex R.
    Dager, William E.
    Zochert, Sara
    Nothdurft, Salli A.
    Gulseth, Michael P.
    [J]. ANNALS OF PHARMACOTHERAPY, 2022, 56 (12) : 1289 - 1298
  • [42] Utilising a hybrid anti-Xa calibration assay in unfractionated heparin (UFH) monitoring: validation of assay and its correlation with activated partial thromboplastin time (aPTT)
    Lukito, Pohan
    Collecutt, Margaret
    Dauer, Raymond
    Morgan, Susan
    Huyen Tran
    [J]. PATHOLOGY, 2016, 48 (05) : 501 - 503
  • [43] Anti-Factor Xa Assay Is a Superior Correlate of Heparin Dose Than Activated Partial Thromboplastin Time or Activated Clotting Time in Pediatric Extracorporeal Membrane Oxygenation
    Liveris, Anna
    Bello, Ricardo A.
    Friedmann, Patricia
    Duffy, Melissa A.
    Manwani, Deepa
    Killinger, James S.
    Rodriquez, Daniel
    Weinstein, Samuel
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2014, 15 (02) : E72 - E79
  • [44] Anticoagulation Monitoring During Extracorporeal Membrane Oxygenation: Is Anti-Factor Xa Assay (Heparin Level) a Better Test?
    Trung Nguyen
    Musick, Matthew
    Teruya, Jun
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2014, 15 (02) : 178 - 179
  • [45] Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti-factor Xa levels
    Schechter, T.
    Finkelstein, Y.
    Ali, M.
    Kahr, W. H.
    Williams, S.
    Chan, A. K.
    Deveber, G.
    Brandao, L. R.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (03) : 368 - 374
  • [46] Achievement of therapeutic anticoagulation with implementation of a new heparin dosing nomogram and monitoring with the anti-factor Xa assay.
    Benipal, Harpreet
    Gundrum, Todd E.
    Jung, Rose
    Murphy, Julie A.
    [J]. PHARMACOTHERAPY, 2014, 34 (10): : E205 - E205
  • [47] INFLUENCE OF ANTITHROMBIN DEFICIENCY AND ELEVATED FACTOR VIII ON HEPARIN ACTIVITY MEASURED BY APTT AND ANTI-FACTOR XA ASSAY IN VITRO
    Kostousov, Vadim
    Kim Nguyen
    Teruya, Jun
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2013, 35 : 72 - 73
  • [48] Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients
    Kulig, Caitlin E.
    Schomer, Kendra J.
    Black, Hugh B.
    Dager, William E.
    [J]. ASAIO JOURNAL, 2021, 67 (04) : 411 - 415
  • [49] Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin
    Vandiver, Jeremy W.
    Vondracek, Thomas G.
    [J]. PHARMACOTHERAPY, 2012, 32 (06): : 546 - 558
  • [50] Concordance between Anti-Factor Xa and Activated Partial Thromboplastin Time Measurements in Syncardia Total Artificial Heart Recipients Receiving Postoperative Anticoagulation with Unfractionated Heparin
    Vela, M. Monteagudo
    Bowles, C.
    Raj, B.
    Simon, A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S447 - S447
12345